Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3697
+0.0222 (6.38%)
Oct 13, 2025, 12:56 PM EDT - Market open
Vaxart Market Cap
Vaxart has a market cap or net worth of $84.45 million as of October 13, 2025. Its market cap has decreased by -52.88% in one year.
Market Cap
84.45M
Enterprise Value
72.14M
1-Year Change
-52.88%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $84.45M, an increase of 39.94%. That is a compound annual growth rate of 4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 79.39M | -47.29% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.71B |
| Johnson & Johnson | 461.14B |
| AbbVie | 411.04B |
| UnitedHealth Group | 322.62B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 231.53B |